Curaleaf Holdings (CURLF) Total Liabilities (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Total Liabilities of $2.0 billion for Q4 2025, up 2.49% year-on-year from $2.0 billion in Q4 2024, and up 2.49% on a QoQ basis from $2.0 billion in Q4 2024.

Curaleaf Holdings (CURLF) Total Liabilities (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Total Liabilities for 7 consecutive years, with $2.0 billion the latest figure, recorded in Q4 2025.

  • Quarterly Total Liabilities rose 2.49% year-over-year to $2.0 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 billion (up 2.49% YoY) and the FY2025 annual result came in at $2.0 billion, up 2.49% from the prior year.
  • Total Liabilities climbed to $2.0 billion in Q4 2025 per CURLF's latest filing, from $2.0 billion in the prior quarter.
  • Over the last five years, Total Liabilities for CURLF reached as high as $2.0 billion in Q3 2023 and fell as low as $1.7 million in Q1 2022.
  • A 5-year average of $1.6 billion and a median of $1.9 billion in 2023 frame the typical range for Total Liabilities.
  • Annual changes were most pronounced in 2021 — Total Liabilities jumped 46.23% — and 2022, when it tumbled 99.84%.
  • Year by year, Total Liabilities stood at $1.4 billion in 2021, then soared by 39.85% to $2.0 billion in 2022, then declined by 4.39% to $1.9 billion in 2023, then gained by 1.61% to $2.0 billion in 2024, then rose by 2.49% to $2.0 billion in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods registered $2.0 billion, $2.0 billion, and $2.0 billion for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 21.48 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 31.81 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.92 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 51.53 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 813.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 22.18 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.50 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.72 Bn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.01 Bn
Dec 31, 2024 1.96 Bn
Sep 30, 2024 1.99 Bn
Jun 30, 2024 1.98 Bn
Dec 31, 2023 1.93 Bn
Sep 30, 2023 2.01 Bn
Jun 30, 2023 2.00 Bn
Dec 31, 2022 2.01 Bn
Sep 30, 2022 1.84 Bn
Jun 30, 2022 1.74 Bn
Mar 31, 2022 1.75 Mn
Dec 31, 2021 1.44 Bn
Sep 30, 2021 1.41 Bn
Jun 30, 2021 1.35 Bn
Mar 31, 2021 1.08 Bn
Dec 31, 2020 984.72 Mn
Sep 30, 2020 973.59 Mn
Dec 31, 2019 333.48 Mn